Study of Active Duty Military Personnel for Environmental Deployment Exposures: Pre- and Post-Deployment Spirometry (STAMPEDE II)

References

1. 1.↵
   1. Morris MJ,
   2. Rawlins FA,
   3. Forbes DA,
   4. Skabelund AJ,
   5. Lucero PF

   . Deployment-related respiratory issues. US Army Med Dep J 2016:Apr-Sep;(2-16):173–178.
2. 2.↵
   1. Weese CB,
   2. Abraham JH

   . Potential health implications associated with particulate matter exposure in deployed settings in southwest Asia. Inhal Toxicol 2009;21(4):291–296.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Morris MJ,
   2. Dodson DW,
   3. Lucero PF,
   4. Haislip GD,
   5. Gallup RA,
   6. Nicholson KL,
   7. Zacher LL

   . Study of active duty military for pulmonary disease related to environmental deployment exposures (STAMPEDE). Am J Respir Crit Care Med 2014;190(1):77–84.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Szema AM,
   2. Peters MC,
   3. Weissinger KM,
   4. Gagliano CA,
   5. Chen JJ

   . New-onset asthma among soldiers serving in Iraq and Afghanistan. Allergy Asthma Proc 2010;31(5):67–71.

   OpenUrlPubMed
5. 5.↵
   1. DelVecchio SP,
   2. Collen JF,
   3. Zacher LL,
   4. Morris MJ

   . The impact of combat deployment on asthma diagnosis and severity. J Asthma 2015;52(4):363–369.

   OpenUrl
6. 6.↵
   Armed Forces Health Surveillance Center. Epidemiological studies of health outcomes among troops deployed to burn pit sites. Silver Spring, MD; 2010.
7. 7.↵
   Institute of Medicine. Long-term health consequences of exposure to burn pits in Iraq and Afghanistan. Washington, DC: The National Academies Press; 2011.
8. 8.↵
   1. Sanders JW,
   2. Putnam SD,
   3. Frankart C,
   4. Frenck RW,
   5. Monteville MR,
   6. Riddle MS,
   7. et al

   . Impact of illness and non-combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan). Am J Trop Med Hyg 2005;73(4):713–719.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Smith B,
   2. Wong CA,
   3. Smith TC,
   4. Boyko EJ,
   5. Gacksetter GD,
   6. Margaret A

   . K. Ryan for the Millennium Cohort Study Team. Newly reported respiratory symptoms and conditions among military personnel deployed to Iraq and Afghanistan: A prospective population-based study. Am J Epidemiol 2009;170(11):1433–1442.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Abraham JH,
    2. Clark LL,
    3. Sharkey JM,
    4. Baird CP

    . Trends in rates of chronic obstructive respiratory conditions among US military personnel, 2001-2013. US Army Med Dep J 2014:Jul-Sep;33–43.
11. 11.↵
    1. Rose C,
    2. Abraham J,
    3. Harkins D,
    4. Miller M,
    5. Morris M,
    6. Zacher L,
    7. et al

    . Overview and recommendations for medical screening and diagnostic evaluation for post-deployment lung disease in returning US warfighters. J Occup Environ Med 2012;54(6):746–751.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Zacher LL,
    2. Browning R,
    3. Bisnett T,
    4. Bennion JR,
    5. Postlewaite RC,
    6. Baird CP

    . Clarifications from representatives of the Department of Defense regarding the article “Recommendations for medical screening and diagnostic evaluation for post-deployment lung disease in returning US warfighters.” J Occup Environ Med 2012;54(6):760–761.

    OpenUrlPubMed
13. 13.↵
    1. Skabelund AJ,
    2. Rawlins FA III.,
    3. McCann ET,
    4. Lospinoso JA,
    5. Burroughs L,
    6. Gallup RA,
    7. Morris MJ

    . Pulmonary function and respiratory health of military personnel before Southwest Asia deployment. Respir Care 2017;62(9):1148–1155.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB

    . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159(1):179–187.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Cochet AA,
    2. Lucero PF,
    3. Zacher LL,
    4. Morris MJ

    . Prevalence of supranormal pulmonary function testing values between a military and non-military cohort. Respir Care 2014;59(5):749–755.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Oostveen E,
    2. MacLeod D,
    3. Lorino H,
    4. Farré R,
    5. Hantos Z,
    6. Desager K,
    7. Marchal F

    ; ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003;22(6):1026–1041.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Bickel S,
    2. Popler J,
    3. Lesnick B,
    4. Eid N

    . Impulse oscillometry: interpretation and practical applications. Chest 2014;146(3):841–847.

    OpenUrlPubMed
18. 18.↵
    1. Anderson DMF,
    2. Morris MJ,
    3. Ondrasik NR,
    4. Rawlins FA III.,
    5. Lospinoso JA,
    6. Zanders TB

    . Screening spirometry in military personnel correlates poorly with exercise tolerance and asthma history. Mil Med 2018 Mar 26. doi: 10.1093/milmed/usx195. [Epub ahead of print]

    OpenUrlCrossRef
19. 19.↵
    1. Baird CP,
    2. Harkins DK

    1. Morris MJ,
    2. Eschenbacher W

    . Discussion summary: recommendation for surveillance spirometry in military personnel. In: Baird CP, Harkins DK, editors. Airborne hazards related to deployment. Fort Sam Houston, Texas: Office of the Surgeon General, Borden Institute; 2015:95–102.
20. 20.↵
    1. Townsend MC,
    2. Lockey JE,
    3. Velez H,
    4. Carson AI,
    5. Cowl CT,
    6. Delclos GL,
    7. et al

    . ACOEM position statement. Spirometry in the occupational setting. American College of Occupational and Environmental Medicine. J Occup Environ Med 2000;42(3):228–245.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Morris MJ,
    2. Grbach VX,
    3. Deal LE,
    4. Boyd SY,
    5. Johnson JE,
    6. Morgan JA

    . Evaluation of exertional dyspnea in the active duty patient: The diagnostic approach and the utility of clinical testing. Mil Med 2002;167(4):281–288.

    OpenUrlPubMedWeb of Science
22. 22.↵
    1. Roop SA,
    2. Niven AS,
    3. Calvin BE,
    4. Bader J,
    5. Zacher LL

    . The prevalence and impact of respiratory symptoms in asthmatics and non-asthmatics during deployment. Mil Med 2007;172(12):1264–1269.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Matthews T,
    2. Abraham J,
    3. Zacher LL,
    4. Morris MJ

    . The impact of deployment on COPD in active duty military personnel. Mil Med 2014;179(11):1273–1278.

    OpenUrl
24. 24.↵
    1. Hamilton J,
    2. McCann E,
    3. Rawlins F,
    4. Morris M

    . The effect of deployment on the severity of sarcoidosis in active duty military. Chest 2014;146 (4 Meeting Abstracts):366A.

    OpenUrl
25. 25.↵
    1. Falvo MJ,
    2. Abraham JH,
    3. Osinubi OY,
    4. Klein JC,
    5. Sotolongo AM,
    6. Ndirangu D,
    7. et al

    . Bronchodilator responsiveness and airflow limitation are associated with deployment length and Iraq and Afghanistan veterans. J Occup Environ Med 2016;58(4):325–328.

    OpenUrl